Ipamorelin Peptide – 2 mg
High-purity peptide designed exclusively for laboratory and scientific research use.
Product Summary
Content: 5 mg lyophilized Ipamorelin peptide
Purity: ≥ 99%
Molecular Formula: C₃₈H₄₉N₉O₅
Molecular Weight: ~711.9 g/mol
Amino Acid Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Origin: Synthetic growth hormone–releasing peptide (GHRP class)
Intended Use: Laboratory and research purposes only
What is Ipamorelin?
Ipamorelin is a selective growth hormone–releasing peptide (GHRP) that stimulates the release of growth hormone (GH) from the anterior pituitary gland. Unlike earlier GHRPs, Ipamorelin exhibits high selectivity for ghrelin receptors and does not significantly affect cortisol or prolactin levels, making it a preferred candidate in longevity and regenerative research.
Potential Research Benefits
Growth Hormone Secretion
Promotes GH release, supporting studies involving muscle growth, tissue repair, and metabolic activity.
Selective Activity
Shows minimal effect on other pituitary hormones (cortisol, prolactin), offering a cleaner pharmacological profile.
Bone and Muscle Health
Explored in research involving sarcopenia, osteoporosis, and age-related muscle loss.
Recovery and Regeneration
Investigated for its role in wound healing, post-injury recovery, and connective tissue regeneration.
Longevity Research
May provide insights into GH/IGF-1 axis modulation in healthy aging studies.
Legal Notice & Disclaimer
For Research Use Only: Not intended for human consumption.
FDA Status: This product has not been evaluated or approved by the U.S. Food and Drug Administration (FDA).
WADA Classification: May be listed as a prohibited substance by the World Anti-Doping Agency (WADA).
Product Details
Packaging: 2 mg lyophilized powder in a sterile glass vial
Storage: Store at 2–8 °C (refrigerated)
Solubility: Soluble in sterile water or bacteriostatic water
After Reconstitution: Recommended for use shortly after reconstitution
Scientific References
Raun, K. et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. https://doi.org/10.1530/eje.0.1390552
Svensson, J. et al. (2003). Growth hormone secretagogues in clinical development. Trends in Endocrinology & Metabolism. https://doi.org/10.1016/S1043-2760(03)00140-0
Garcia, J.M. et al. (2013). The ghrelin axis and cancer-associated cachexia. Nature Reviews Endocrinology. https://doi.org/10.1038/nrendo.2013.56
Contact & Orders
At TFLL Pharma, we are committed to providing research-grade peptides of the highest purity and quality.
For more information or to place an order for 2 mg Ipamorelin, please contact us.
Note: This product is strictly for research purposes. Its use must comply with local regulations and ethical research standards.
